Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Income towards Parent Company: 2020

Historic Income towards Parent Company for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$3.9 million.

  • Design Therapeutics' Income towards Parent Company was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
  • Design Therapeutics' Income towards Parent Company amounted to -$3.9 million in Q4 2020, which was down 62.02% from -$2.4 million recorded in Q3 2020.
  • In the past 5 years, Design Therapeutics' Income towards Parent Company registered a high of -$623,000 during Q1 2020, and its lowest value of -$3.9 million during Q4 2020.
  • Moreover, its 1-year median value for Income towards Parent Company was -$1.9 million (2020), whereas its average is -$2.1 million.